SEARCH

SEARCH BY CITATION

References

  • Adachi N., Liu K. and Arai T. (2005) Prevention of brain infarction by postischemic administration of histidine in rats. Brain Res. 1039, 220223.
  • Aghajanian G. K. and Vandermaelen C. P. (1982) Intracellular recordings from serotonergic dorsal raphe neurons: pacemaker potentials and the effect of LSD. Brain Res. 238, 463469.
  • Alewijnse A. E., Smit M. J., Hoffmann M., Verzijl D., Timmerman H. and Leurs R. (1998) Constitutive activity and structural instability of the wild-type human H2 receptor. J. Neurochem. 71, 799807.
  • Alewijnse A. E., Timmerman H., Jacobs E. H., Smit M. J., Roovers E., Cotecchia S. and Leurs R. (2000) The effect of mutations in the DRY motif on the constitutive activity and structural instability of the histamine H(2) receptor. Mol. Pharmacol. 57, 890898.
  • Alexander G. E. and Crutcher M. D. (1990) Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci. 13, 266271.
  • Anichtchik O. V., Rinne J. O., Kalimo H. and Panula P. (2000) An altered histaminergic innervation of the substantia nigra in Parkinson’s disease. Exp. Neurol. 163, 2030.
  • Anichtchik O. V., Peitsaro N., Rinne J. O., Kalimo H. and Panula P. (2001) Distribution and modulation of histamine H(3) receptors in basal ganglia and frontal cortex of healthy controls and patients with Parkinson’s disease. Neurobiol. Dis. 8, 707716.
  • Black J. W., Duncan W. A., Durant C. J., Ganellin C. R. and Parsons E. M. (1972) Definition and antagonism of histamine H 2 -receptors. Nature 236, 385390.
  • Brown R. E., Stevens D. R. and Haas H. L. (2001) The physiology of brain histamine. Prog. Neurobiol. 63, 637672.
  • Bunin M. A., Prioleau C., Mailman R. B. and Wightman R. M. (1998) Release and uptake rates of 5-hydroxytryptamine in the dorsal raphe and substantia nigra reticulata of the rat brain. J. Neurochem. 70, 10771087.
  • Chen K., Zhu J. N., Li H. Z. and Wang J. J. (2003) Histamine elicits neuronal excitatory response of red nucleus in the rat via H2 receptors in vitro. Neurosci. Lett. 351, 2528.
  • Chen K., Wang J. J., Yung W. H., Chan Y. S. and Chow B. K. (2005) Excitatory effect of histamine on neuronal activity of rat globus pallidus by activation of H2 receptors in vitro. Neurosci. Res. 53, 288297.
  • Cobb W. S. and Abercrombie E. D. (2003) Differential regulation of somatodendritic and nerve terminal dopamine release by serotonergic innervation of substantia nigra. J. Neurochem. 84, 576584.
  • Corvaja N., Doucet G. and Bolam J. P. (1993) Ultrastructure and synaptic targets of the raphe-nigral projection in the rat. Neuroscience 55, 417427.
  • Cragg S. J. and Greenfield S. A. (1997) Differential autoreceptor control of somatodendritic and axon terminal dopamine release in substantia nigra, ventral tegmental area, and striatum. J. Neurosci. 17, 57385746.
  • Cragg S. J., Hawkey C. R. and Greenfield S. A. (1997) Comparison of serotonin and dopamine release in substantia nigra and ventral tegmental area: region and species differences. J. Neurochem. 69, 23782386.
  • Di Matteo V., De Blasi A., Di Giulio C. and Esposito E. (2001) Role of 5-HT(2C) receptors in the control of central dopamine function. Trends Pharmacol. Sci. 22, 229232.
  • Esbenshade T. A., Kang C. H., Krueger K. M., Miller T. R., Witte D. G., Roch J. M., Masters J. N. and Hancock A. A. (2003) Differential activation of dual signaling responses by human H1 and H2 histamine receptors. J. Recept. Signal Transduct. Res. 23, 1731.
  • Garcia-Ramirez M., Aceves J. and Arias-Montano J. A. (2004) Intranigral injection of the H3 agonist immepip and systemic apomorphine elicit ipsilateral turning behaviour in naive rats, but reduce contralateral turning in hemiparkinsonian rats. Behav. Brain Res. 154, 409415.
  • Gartside S. E., Hajos-Korcsok E., Bagdy E., Harsing Jr L. G., Sharp T. and Hajos M. (2000) Neurochemical and electrophysiological studies on the functional significance of burst firing in serotonergic neurons. Neuroscience 98, 295300.
  • Gomez-Ramirez J., Johnston T. H., Visanji N. P., Fox S. H. and Brotchie J. M. (2006) Histamine H3 receptor agonists reduce L-dopa-induced chorea, but not dystonia, in the MPTP-lesioned nonhuman primate model of Parkinson’s disease. Mov. Disord. 6, 839846.
  • Van Der Goot H. and Timmerman H. (2000) Selective ligands as tools to study histamine receptors. Eur. J. Med. Chem. 35, 520.
  • Haas H. L. and Bucher U. M. (1975) Histamine H2-receptors on single central neurones. Nature 255, 634635.
  • Haas H. L. and Greene R. W. (1986) Effects of histamine on hippocampal pyramidal cells of the rat in vitro. Exp. Brain Res. 62, 123130.
  • Haas H. L. and Konnerth A. (1983) Histamine and noradrenaline decrease calcium-activated potassium conductance in hippocampal pyramidal cells. Nature 302, 432434.
  • Haas H. L. and Wolf P. (1977) Central actions of histamine: microelectrophoretic studies. Brain Res. 122, 269279.
  • Hajos M. and Sharp T. (1996a) A 5-hydroxytryptamine lesion markedly reduces the incidence of burst-firing dorsal raphe neurones in the rat. Neurosci. Lett. 204, 161164.
  • Hajos M. and Sharp T. (1996b) Burst-firing activity of presumed 5-HT neurones of the rat dorsal raphe nucleus: electrophysiological analysis by antidromic stimulation. Brain Res. 740, 162168.
  • Hajos M., Gartside S. E., Villa A. E. and Sharp T. (1995) Evidence for a repetitive (burst) firing pattern in a sub-population of 5-hydroxytryptamine neurons in the dorsal and median raphe nuclei of the rat. Neuroscience 69, 189197.
  • Hajos M., Sharp T. and Newberry N. R. (1996) Intracellular recordings from burst-firing presumed serotonergic neurones in the rat dorsal raphe nucleus in vivo. Brain Res. 737, 308312.
  • Hamami G., Adachi N., Liu K. and Arai T. (2004) Alleviation of ischemic neuronal damage by histamine H2 receptor stimulation in the rat striatum. Eur. J. Pharmacol. 484, 167173.
  • Iravani M. M. and Kruk Z. L. (1997) Real-time measurement of stimulated 5-hydroxytryptamine release in rat substantia nigra pars reticulata brain slices. Synapse 25, 93102.
  • Jacobs B. L. and Fornal C. A. (1993) 5-HT and motor control: a hypothesis. Trends Neurosci. 16, 346352.
  • John C. E., Budygin E. A., Mateo Y. and Jones S. R. (2006) Neurochemical characterization of the release and uptake of dopamine in ventral tegmental area and serotonin in substantia nigra of the mouse. J. Neurochem. 96, 267282.
  • Lakoski J. M. and Aghajanian G. K. (1983) Effects of histamine, H1- and H2-receptor antagonists on the activity of serotonergic neurons in the dorsal raphe nucleus. J. Pharmacol. Exp. Ther. 227, 517523.
  • Lefkowitz R. J., Cotecchia S., Samama P. and Costa T. (1993) Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends Pharmacol. Sci. 14, 303307.
  • Malagelada C., Xifro X., Badiola N., Sabria J. and Rodriguez-Alvarez J. (2004) Histamine H2-receptor antagonist ranitidine protects against neural death induced by oxygen-glucose deprivation. Stroke 35, 23962401.
  • Meltzer H. (1989) Serotonergic dysfunction in depression. Br. J. Psychiatry Suppl., 8, 2531.
  • Monczor F., Legnazzi B. L., Rivera E. and Davio C. (1998) Tiotidine, a classical H2-antagonist, presents characteristics of an inverse agonist in U937 cell line. Inflamm. Res. 47(Suppl 1), S42S43.
  • Monczor F., Fernandez N., Legnazzi B. L., Riveiro M. E., Baldi A., Shayo C. and Davio C. (2003) Tiotidine, a histamine H2 receptor inverse agonist that binds with high affinity to an inactive G-protein-coupled form of the receptor. Experimental support for the cubic ternary complex model. Mol. Pharmacol. 64, 512520.
  • Morisset S., Rouleau A., Ligneau X., Gbahou F., Tardivel-Lacombe J., Stark H., Schunack W., Ganellin C. R., Schwartz J. C. and Arrang J. M. (2000) High constitutive activity of native H3 receptors regulates histamine neurons in brain. Nature 408, 860864.
  • Moukhles H., Bosler O., Bolam J. P., Vallee A., Umbriaco D., Geffard M. and Doucet G. (1997) Quantitative and morphometric data indicate precise cellular interactions between serotonin terminals and postsynaptic targets in rat substantia nigra. Neuroscience 76, 11591171.
  • Nicholson S. L. and Brotchie J. M. (2002) 5-hydroxytryptamine (5-HT, serotonin) and Parkinson’s disease – opportunities for novel therapeutics to reduce the problems of levodopa therapy. Eur. J. Neurol. 9(Suppl 3), 16.
  • Oda T. and Matsumoto S. (2001) Identification and characterization of histamine H4 receptor. Nippon Yakurigaku Zasshi 118, 3642.
  • Panula P., Pirvola U., Auvinen S. and Airaksinen M. S. (1989) Histamine-immunoreactive nerve fibers in the rat brain. Neuroscience 28, 585610.
  • Paxinos G. and Watson C. (1982) The Rat Brain in Stereotaxic Coordinates. Academic Press, San Diego.
  • Pillot C., Heron A., Cochois V., Tardivel-Lacombe J., Ligneau X., Schwartz J. C. and Arrang J. M. (2002) A detailed mapping of the histamine H(3) receptor and its gene transcripts in rat brain. Neuroscience 114, 173193.
  • Poli E., Todorov S., Pozzoli C. and Bertaccini G. (1994) Presynaptic histamine H2 receptors modulate the sympathetic nerve transmission in the isolated rat vas deferens; no role for H3-receptors. Agents Actions 42, 95100.
  • Prast H., Tran M. H., Lamberti C., Fischer H., Kraus M., Grass K. and Philippu A. (1999) Histaminergic neurons modulate acetylcholine release in the ventral striatum: role of H1 and H2 histamine receptors. Naunyn Schmiedebergs Arch. Pharmacol. 360, 552557.
  • Rice M. E. and Nicholson C. (1989) Measurement of nanomolar dopamine diffusion using low-noise perfluorinated ionomer coated carbon fiber microelectrodes and high-speed cyclic voltammetry. Anal. Chem. 61, 18051810.
  • Rick C. E., Stanford I. M. and Lacey M. G. (1995) Excitation of rat substantia nigra pars reticulata neurons by 5-hydroxytryptamine in vitro: evidence for a direct action mediated by 5-hydroxytryptamine2C receptors. Neuroscience 69, 903913.
  • Smit M. J., Leurs R., Alewijnse A. E., Blauw J., Van Nieuw Amerongen G. P., Van De Vrede Y., Roovers E. and Timmerman H. (1996) Inverse agonism of histamine H2 antagonist accounts for upregulation of spontaneously active histamine H2 receptors. Proc. Natl Acad. Sci. USA 93, 68026807.
  • Stanford I. M. and Lacey M. G. (1996) Differential actions of serotonin, mediated by 5-HT1B and 5-HT2C receptors, on GABA-mediated synaptic input to rat substantia nigra pars reticulata neurons in vitro. J. Neurosci. 16, 75667573.
  • Thomson A. M. (2000) Molecular frequency filters at central synapses. Prog. Neurobiol. 62, 159196.
  • Threlfell S., Cragg S. J., Kallo I., Turi G. F., Coen C. W. and Greenfield S. A. (2004) Histamine H3 receptors inhibit serotonin release in substantia nigra pars reticulata. J. Neurosci. 24, 87048710.
  • Timm J., Marr I., Werthwein S., Elz S., Schunack W. and Schlicker E. (1998) H2 receptor-mediated facilitation and H3 receptor-mediated inhibition of noradrenaline release in the guinea-pig brain. Naunyn Schmiedebergs Arch. Pharmacol. 357, 232239.
  • Venton B. J., Michael D. J. and Wightman R. M. (2003) Correlation of local changes in extracellular oxygen and pH that accompany dopaminergic terminal activity in the rat caudate-putamen. J. Neurochem. 84, 373381.
  • Vizuete M. L., Traiffort E., Bouthenet M. L., Ruat M., Souil E., Tardivel-Lacombe J. and Schwartz J. C. (1997) Detailed mapping of the histamine H2 receptor and its gene transcripts in guinea-pig brain. Neuroscience 80, 321343.
  • Zhou F. W., Xu J. J., Zhao Y., LeDoux M. S. and Zhou F. M. (2006) Opposite functions of histamine H1 and H2 receptors and H3 receptor in substantia nigra pars reticulata. J. Neurophysiol. 96, 15811591.